Mizuho Securities USA’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Mizuho Securities USA's GILD Position: Q1 2026 in Review
Mizuho Securities USA reduced its Gilead Sciences (GILD) stake by 17% in Q1 2026, selling an estimated $2.15M and leaving 75,005 shares worth $10.5M. The position accounts for 0.25% of the portfolio, ranked #79.
Mizuho Securities USA first reported a position in GILD in Q2 2013 and has held it in 18 quarters since. The position peaked at $13.9M in Q4 2013. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Mizuho Securities USA held 75,005 shares of Gilead Sciences worth $10.5M as of Q1 2026.
- Mizuho Securities USA sold 15,333 Gilead Sciences shares in Q1 2026, an estimated $2.15M.
- Gilead Sciences made up 0.25% of Mizuho Securities USA's portfolio in Q1 2026, its #79 holding.
- Mizuho Securities USA first reported a position in Gilead Sciences in Q2 2013 and has held it in 18 quarters since.
- Mizuho Securities USA's Gilead Sciences position peaked at $13.9M in Q4 2013.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Mizuho Securities USA's 13F filing for Q1 2026, filed 11 May 2026.